Purchases and Sales Made in Q4 2024 in Arbutus Biopharma Corp (ABUS)
This table provides information about the institutional ownership of Arbutus Biopharma Corp (ABUS) during Q4 2024. The information is specifically focused on institutions that hold shares of Arbutus Biopharma Corp.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Virtus ETF Advisers LLC
New York, NY |
SELL
|
- |
-9.19K- 31.52% |
$29.2K - $38.6K
|
20K
$62.7K
|
|
|
Feb 14, 2025
Q4 2024
|
Centiva Capital, LP
New York, NY |
SELL
|
- |
-9.28K- 23.19% |
$29.5K - $39K
|
30.7K
$96.5K
|
|
|
Feb 07, 2025
Q4 2024
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-9.93K- 0.72% |
$31.6K - $41.7K
|
1.36M
$4.28M
|
|
|
May 29, 2025
Q4 2024
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-12.2K- 6.06% |
$38.7K - $51.1K
|
189K
$592K
|
|
|
Feb 12, 2025
Q4 2024
|
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
|
SELL
|
- |
-12.3K- 14.99% |
$39.1K - $51.6K
|
69.7K
$219K
|
|
|
Feb 12, 2025
Q4 2024
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-17.4K- 12.63% |
$55.3K - $73K
|
120K
$378K
|
|
|
Feb 13, 2025
Q4 2024
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-27.1K- 18.59% |
$86.2K - $114K
|
119K
$373K
|
|
|
Feb 11, 2025
Q4 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-28.5K- 5.09% |
$90.7K - $120K
|
532K
$1.67M
|
|
|
Feb 14, 2025
Q4 2024
|
Lmr Partners LLP
London, X0 |
SELL
|
- |
-38.8K- 19.68% |
$123K - $163K
|
158K
$497K
|
|
|
Feb 11, 2025
Q4 2024
|
Simplex Trading, LLC
|
SELL
|
- |
-45.4K- 69.51% |
$144K - $191K
|
19.9K
$62.5K
|
|
|
Feb 14, 2025
Q4 2024
|
Ubs Group Ag
|
SELL
|
- |
-67.4K- 40.01% |
$214K - $283K
|
101K
$317K
|
|
|
Feb 14, 2025
Q4 2024
|
State Of Wisconsin Investment Board
Madison, WI |
SELL
|
- |
-84.9K- 86.14% |
$270K - $357K
|
13.7K
$42.9K
|
|
|
Feb 14, 2025
Q4 2024
|
Ubs Asset Management Americas Inc
Chicago, IL |
SELL
|
- |
-91.9K- 46.93% |
$292K - $386K
|
104K
$326K
|
|
|
Feb 11, 2025
Q4 2024
|
Corbin Capital Partners, L.P.
New York, NY |
SELL
|
- |
-171K- 20.02% |
$543K - $717K
|
682K
$2.14M
|
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-330K- 54.33% |
$1.05M - $1.39M
|
278K
$872K
|
|
|
Feb 14, 2025
Q4 2024
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-450K- 73.5% |
$1.43M - $1.89M
|
162K
$510K
|
|
|
Feb 13, 2025
Q4 2024
|
Adar1 Capital Management, LLC
Austin, TX |
SELL
|
- |
-535K- 25.58% |
$1.7M - $2.24M
|
1.55M
$4.88M
|
|
|
Feb 14, 2025
Q4 2024
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-1.25M- 43.09% |
$3.98M - $5.25M
|
1.65M
$5.18M
|
|
|
Feb 14, 2025
Q4 2024
|
Four World Capital Management LLC
New York, NY |
SELL
|
- |
-1.75M- 58.73% |
$5.55M - $7.33M
|
1.23M
$3.85M
|